Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

a Prospective, Single-arm, Symptom-based Score, to Evaluate the Tolerance of Extensive Hydrolyzed Whey Protein Milk Intervention Among Infant With Mild to Moderate CMPA

NCT06204770 is registered in ClinicalTrials.gov with Danone Specialized Nutrition Indonesia as lead sponsor.

NCT NCT06204770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06204770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
a Prospective, Single-arm, Symptom-based Score, to Evaluate the Tolerance of Extensive Hydrolyzed Whey Protein Milk Intervention Among Infant With Mild to Moderate CMPA
Lead sponsor
Danone Specialized Nutrition Indonesia
Phase
Phase 4
Overall status
Terminated
Start date
July 14, 2023
Completion date
January 31, 2024
Enrollment
15 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

mild to moderate cows' milk protein allergy